William A Petri

Title: The Innovations of William A. Petri

Introduction

William A. Petri is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical research, particularly in the development of PEGylated liposomes. With a total of 10 patents to his name, Petri's work has the potential to impact vaccine delivery and therapeutic applications.

Latest Patents

One of Petri's latest patents focuses on PEGylated liposomes and methods of use. These liposomes are designed to include cholesterol, a non-PEGylated neutral lipid, and a PEGylated lipid. The average molecular weight of the PEG component in the PEGylated lipid is about 5000 Daltons or less. The stability of these PEGylated liposomes allows for the effective delivery of agents that can generate an immune response, making them suitable for vaccine, therapeutic, or diagnostic uses. The patent also outlines compositions and methods related to the creation and application of these liposomes for stimulating immune responses.

Career Highlights

Throughout his career, William A. Petri has been associated with notable institutions such as the University of Virginia and Access to Advanced Health Institute. His work in these organizations has furthered the understanding and application of innovative biomedical technologies.

Collaborations

Petri has collaborated with esteemed colleagues, including Barbara J. Mann and R. Randolph Vines. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

William A. Petri's contributions to the field of biomedical research through his innovative patents on PEGylated liposomes demonstrate his commitment to advancing healthcare solutions. His work continues to pave the way for new therapeutic approaches and improved vaccine delivery systems.